Ronen Tsimerman

Chief Financial Officer, Lifeward Ltd.

Incoming, effective November 1, 2026. First published here October 28, 2026; built from records as of October 28, 2026.

Ronen Tsimerman is due to become Chief Financial Officer of Lifeward Ltd. on November 1, 2026, according to a filing the company made on October 27, 2026.¹

The filing gives Ronen Tsimerman's previous role as chief financial officer at Scopio Labs Ltd.¹ Ronen Tsimerman joined from outside Lifeward Ltd., by the record's reading of the filing.¹ The filing shows an earlier chief financial officer seat, so this is not Ronen Tsimerman's first.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Lifeward Ltd. (LFWD) Orthopedic, Prosthetic & Surgical Appliances & Supplies	Chief Financial Officer	Incoming, effective November 1, 2026	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

November 1, 2026takes effect
Lifeward Ltd. appointed Ronen Tsimerman as Chief Financial Officer, effective November 1, 2026.
On October 26, 2026, the Board of Directors (the “Board”) of Lifeward Ltd. (the “Company”) appointed Ronen Tsimerman, age 56, as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, effective November 1, 2026.
[1] Filing by Lifeward Ltd., filed with the SEC on October 27, 2026. Read the filing. The record at CFO Tribune.

Sources

Current report filed with the SEC, Lifeward Ltd.. U.S. Securities and Exchange Commission, EDGAR, filed October 27, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Ronen Tsimerman wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.